Repros Therapeutics' Pending Acquisition

Repros Therapeutics raised a round of funding on December 13, 2017. Investors include Allergan.

Repros Therapeutics, formerly Zonagen, focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.…

Articles about Repros Therapeutics' Pending Acquisition: